The integrated metabolomics and network pharmacology indicated that AKT1, EGFR, ESR1, STAT3, IGF1, and MAPK1 may be key targets for EGCG in preventing obesity-related precocious puberty. The gene discussed is EGFR; the disease is obesity due to melanocortin 4 receptor deficiency.